As modern vehicles become increasingly software-driven and OEMs continue to tighten security, the company has had to work ...
Approval covers all current IV isatuximab indications and introduces the first oncology product labeled for both OBI and manual SC administration. IRAKLIA (NCT05405166) established noninferiority of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results